Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is one of the best cheap biotech stocks to buy now. Aurinia Pharmaceuticals Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 12,229,500 | $181,241,190 | +8% | 9.2% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 3,428,705 | $50,813,408 | +163% | 0.04% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,284,368 | $48,674,334 | -4% | 0.03% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,874,597 | $27,781,530 | +20% | 0.03% |
| 5. | Renaissance Technologies Jim Simons | 1,663,835 | $24,658,035 | +5% | 0.04% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.22 | 184,208 | $2,619,437.76 | 12,229,500 | 2026-03-03 | Filing | |
| $14.21 | 115,792 | $1,645,404.32 | 12,045,292 | 2026-03-02 | Filing | |
| $14.33 | 83,561 | $1,197,429.13 | 11,929,500 | 2026-03-02 | Filing | |
| $14.38 | 1,600 | $23,008.00 | 11,845,939 | 2026-02-27 | Filing | |
| $14.12 | 214,839 | $3,033,526.68 | 11,844,339 | 2026-02-27 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.50 | 20,000 | $210,000.00 | 133,484 | 2025-08-01 | Filing | |
| $8.23 | 8,305 | $68,350.15 | 153,484 | 2025-03-07 | Filing | |
| $7.92 | 164,947 | $1,306,380.24 | 1,788,945 | 2025-03-04 | Filing | |
| $8.00 | 195,593 | $1,564,744.00 | 1,953,892 | 2025-03-03 | Filing | |
| $8.00 | 12,239 | $97,912.00 | 161,789 | 2025-03-03 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,845,521 | $116,270,621 | 0% | |
| 2. | 3,969,834 | $58,832,940 | 3.34% | |
| 3. | 2,527,099 | $37,451,607 | 0% | |
| 4. | 2,232,548 | $33,086,365 | 0% | |
| 5. | 1,536,009 | $22,760,482 | 0% |